“Reprogrammed” Cells in Mice Reverse Late-stage Type 1 Diabetes

Diabetes Health Staff

May 15, 2012

A successful experiment on mice with type 1 diabetes, which involved "reprogramming" their immune systems to stop attacks on pancreatic beta cells, may point the way to an eventual cure for the disease in humans.

The experiment, led by the City of Hope medical research center in Duarte, California, first used antibodies to kill the two kinds of cells that are involved in autoimmune attacks against insulin-producing beta cells in the pancreas. In type 1 diabetes, the cells that defend the body against bacteria, viruses, and outside intruders erroneously attack the beta cells, eventually destroying them and the body's ability to produce insulin.

Once the defender cells were killed, the researchers transplanted bone marrow into the mice to restore the cells. The new immune cells from the marrow no longer carried the factor that made the previous cells attack the pancreas's insulin-making beta cells. In short, the new cells left the mice's pancreases alone.

At the same time, the researchers injected the diabetic mice with pancreas growth factor, which led to the creation of new insulin-producing beta cells. The cessation of autoimmune attacks, combined with a restored ability to produce insulin, led to a virtual cure of the mice's disease.

Two aspects of the study give rise to high hopes for its treatment approach. First, it involved mice that had late-stage type 1 diabetes. Second, it combined cell replacement and pancreatic growth factor, two therapies that are not new but had not been combined before.

As promising as the City of Hope approach is, it will be several years before it can be used experimentally on humans. The next step will be to try the treatment on primates, which are physiologically closer to humans than mice are.

The study, funded by the Iacocca Family Foundation and private donations, was published in Science Translational Medicine.

Categories: Diabetes, Diabetes, Diabetes Health, Insulin, Pancreas, Pancreatic Beta Cells, Research, Science Translational Medicine, Type 1, Type 1 Diabetes, Type 1 Issues

Comments

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Registered User Anonymous

Your Name:	Your Email:	X

Recipient's Name:	Recipient's Email:

Your Chosen Username:	Your Email Address:

Chosen Password:	Confirm Password:

Email to a Friend

“Reprogrammed” Cells in Mice Reverse Late-stage Type 1 Diabetes

You May Also Be Interested In...

Comments

Register...

Have Your Say...

Diabetes Health

Topics

Topics

Topics

Diabetes Health Medical Disclaimer

Comment: